XLO
Xilio TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
XLO Profile
Xilio Therapeutics, Inc.
A biotech company that develops tumor-selective immuno-oncology therapies for cancer
828 Winter Street, Suite 300, Waltham, MA 02451
--
Xilio Therapeutics, Inc., was incorporated in Delaware on June 18, 2020. The company is a biotechnology company focused on leveraging the immune system to achieve deep and durable clinical responses to improve the lives of cancer patients. The company has built geographically precise solutions, or GPS platforms, to rapidly design new molecules, including cytokines and biological agents, that are designed to optimize their therapeutic indices by geographically targeting their activity within the tumor. The company is advancing some geographically precise or tumor-selective drugs through different stages of development. The company also plans to continue to develop more immunotherapies using their GPS platform, including product candidates with a range of tumor-targeting approaches.
